1-9 of 9
Deepak Bararia, PhD
Close
Sort by
Journal Articles

Clinicogenetic Risk Models in Patients Randomized to Receive Consolidative Autologous Stem-Cell Transplantation after Frontline R-CHOP for Advanced Follicular Lymphoma: An Analysis from the GLSG2000 Trial

Stefan Alig, MD, Alessandro Pastore, Vindi Jurinovic, Sarah Häbe, Deepak Bararia, PhD, Verena Passerini, PhD, William Keay, Johannes Hellmuth, Andreas Rosenwald, Wolfram Klapper, MD, Harald Stein, MD PhD Dr. h.c., Alfred Feller, German Ott, MD, Annette M. Staiger, PhD, Heike Horn, Martin-Leo Hansmann, Christiane Pott, Roswitha Forstpointner, Wolf-Karsten Hofmann, Norbert Schmitz, MD, Georg Hess, Michael Unterhalt, Martin H. Dreyling, MD PhD, Anna-Katharina Zoellner, Christian Schmidt, MD, Eva Hoster, Wolfgang Hiddemann, Oliver Weigert, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4096.
https://doi.org/10.1182/blood-2018-99-118000
Published: 2018
Journal Articles

The Lysine Acetyltransferase Tip60 Is Required for Hematopoietic Stem Cell Maintenance

Akihiko Numata, MD, Hui Si Kwok, PhD, Qi-Ling Zhou, Jia Li, PhD, Rebecca Hannah, Jihye Park, PhD, Vladimir Espinosa Angarcia, PhD, Berthold Gottgens, Henry Yang, PhD, John Lough, PhD, Deepak Bararia, PhD, Daniel G. Tenen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2554.
https://doi.org/10.1182/blood-2018-99-118316
Published: 2018
Journal Articles

PARP14 Is a Novel Therapeutic Target in STAT6 mutant Follicular Lymphoma

Verena Passerini, PhD, Michael Boesl, Elisabeth Silkenstedt, MD, Elisa Osterode, Michael Heide, Robert Kridel, PhD MD, Christoph Ziegenhain, Annette M. Staiger, PhD, German Ott, MD, Monika Szczepanowski, PhD, Julia Richter, PhD, Wolfram Klapper, MD, Andreas Rosenwald, Wolfgang Enard, PhD, Wolfgang Hiddemann, Deepak Bararia, PhD, Zimber-Strobl Ursula, Dr., Oliver Weigert, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2842.
https://doi.org/10.1182/blood-2018-99-118063
Published: 2018
Journal Articles

STAT6 Is Recurrently and Significantly Mutated in Follicular Lymphoma and Enhances the IL-4 Induced Expression of Membrane-Bound and Soluble CD23

Michael W Bösl, Elisa Osterode, Deepak Bararia, PhD, Alessandro Pastore, MD, Anette M Staiger, German Ott, MD, Monika Szczepanowski, PhD, Wolfram Klapper, MD, Andreas Rosenwald, MD, Wolfgang Hiddemann, MD, Oliver Weigert, MD
Journal: Blood
Blood (2015) 126 (23): 3923.
https://doi.org/10.1182/blood.V126.23.3923.3923
Published: 2015
Journal Articles

Disruptive ARID1A Mutations in Follicular Lymphoma Impair DNA Repair Efficiency and Are Associated with Favorable Outcome in Patients Receiving First-Line Immunochemotherapy

Deepak Bararia, PhD, Michael Heide, Robert S. Welner, PhD, Tatiana Romashova, Alessandro Pastore, MD, Radhika Mathur, Randy D. Gascoyne, Robert Kridel, MD MPH, Boris G. Willson, PhD, Charles W.M. Roberts, MD PhD, Wolfgang Hiddemann, MD PhD, David M Weinstock, MD, Oliver Weigert, MD
Journal: Blood
Blood (2015) 126 (23): 571.
https://doi.org/10.1182/blood.V126.23.571.571
Published: 2015
Journal Articles

Relationship Between Self-Renewal and Differentiation Pathways in Stem Cells and Leukemia

Robert S Welner, PhD, Danielle E Tenen, BA, Henry Yang, PhD, Deepak Bararia, PhD, Giovanni Amabile, PhD, Daniel G. Tenen, MD
Journal: Blood
Blood (2014) 124 (21): 4789.
https://doi.org/10.1182/blood.V124.21.4789.4789
Published: 2014
Journal Articles

ARID1A Is Recurrently and Significantly Mutated in Follicular Lymphoma (FL) and Impairs DNA Repair Efficiency

Deepak Bararia, PhD, Michael Heide, Tatiana Romashova, Pastore Alessandro, MD, Boris G. Wilson, PhD, Charles W.M. Roberts, MD PhD, Wolfgang Hiddemann, MD PhD, David M. Weinstock, MD, Oliver Weigert, MD
Journal: Blood
Blood (2014) 124 (21): 73.
https://doi.org/10.1182/blood.V124.21.73.73
Published: 2014
Journal Articles

Sociology of Normal Stem and Progenitor Cells in CML Niche

Robert S Welner, PhD, Giovanni Amabile, PhD, Deepak Bararia, PhD, Philipp B. Staber, M.D., Akos G. Czibere, MD, PhD, Daniel G Tenen, MD
Journal: Blood
Blood (2012) 120 (21): 1234.
https://doi.org/10.1182/blood.V120.21.1234.1234
Published: 2012
Journal Articles

The Leukemogenic Potential of Cdx2 Is Dependent on Its N-Terminal Serine Sites and Can Be Counteracted by MAPK Inhibitors

Vijay P.S. Rawat, PhD, Vegi M. Naidu, MSc, Deepak Bararia, PhD, Silvia Thoene, MSc, Farid Ahmed, PhD, Leticia Quintanilla-Martinez, MD, Wolfgang Hiddemann, Stefan Bohlander, Michaela Feuring-Buske, MD, Christian Buske, MD
Journal: Blood
Blood (2008) 112 (11): 3784.
https://doi.org/10.1182/blood.V112.11.3784.3784
Published: 2008